Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GLP-1 analogue exenatide on abdominal fat in obese patients with type 2 diabetes mellitus
ChiCTR-OPC-16008152Phase 4Completed
- Sponsor
- Changzhou Second People's Hospital
- Start
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of exenatide in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by Changzhou Second People's Hospital. Primary endpoint: Intra-abdominal fat area. Started Dec 2014; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on ChiCTR-OPC-16008152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008152.